Track the Concord Biotech Limited stock price and the full insider trade history of the company, a listed issuer based in India. Shares are listed on the IN market, under the supervision of SEBI (PIT + SAST). Operating in the Health Care sector, Concord Biotech Limited has published 9 insider filings. Market capitalisation: €148.6bn. The latest transaction was filed on 23 September 2024 (Sale). Among the most active insiders: UTPAL SHETH. Every trade is accessible without an account.
9
Insider Decl.
n/a
Thresholds
€24,948
2 ops.
Buy Volume
€2m
7 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Concord Biotech Limited Buy (bullish), based on 5 analysts. Average price target: ₹1,216.00.
10Σ signal
Buys €24,948€2m Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 9,562 of 28,717 companies
59.8
score / 100
Value
32
Quality
88
FCF yld1.2%
Earn yld1.8%
EV/EBITDA35.4x
ROE14%
Gross mgn75%
Net mgn25%
Debt/EBITDA0.0x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.